12.94

1.25% 0.16

After Hours: 13.00 0.06 +0.46%

Nurix Therapeutics Inc (NRIX)

Overview News Price History Option Chain Financials Discussions Forecast

Nurix Therapeutics Inc stock is traded at $12.94, with a volume of 1.68M. It is up +1.25% in the last 24 hours and up +40.04% over the past month. Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.

Previous Close:

$12.78

Open:

$12.61

24h Volume:

1.68M

Relative Volume:

1.43

Market Cap:

$989.25M

Revenue:

$54.55M

Net Income/Loss:

$-193.57M

P/E Ratio:

-4.4775

EPS:

-2.89

Net Cash Flow:

$-181.86M

1W Performance:

+16.68%

1M Performance:

+40.04%

6M Performance:

+12.23%

1Y Performance:

-47.36%

1-Day Range:

$12.46

$13.19

1-Week Range:

$11.19

$13.23

52-Week Range:

$8.18

$29.56

Nurix Therapeutics Inc Stock (NRIX) Company Profile

Name

Nurix Therapeutics Inc

Sector

Healthcare (1135)

Industry

Biotechnology (635)

Phone

(415) 660-5320

Address

1700 OWENS STREET, SUITE 205, SAN FRANCISCO

Employee

286

Twitter

Next Earnings Date

2025-10-09

Latest SEC Filings

NRIX's Discussions on Twitter

Compare NRIX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
NRIX Nurix Therapeutics Inc	12.94	1.30B	54.55M	-193.57M	-181.86M	-2.89
VRTX Vertex Pharmaceuticals Inc	425.57	107.66B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	651.80	68.74B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	456.04	58.93B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	818.50	50.51B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	189.60	41.29B	447.02M	-1.18B	-868.57M	-6.1812

Nurix Therapeutics Inc Stock (NRIX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-21-25	Initiated	Mizuho	Outperform
Mar-17-25	Initiated	Leerink Partners	Market Perform
Dec-10-24	Initiated	BTIG Research	Buy
Dec-06-24	Initiated	BMO Capital Markets	Outperform
Oct-24-24	Initiated	UBS	Buy
Oct-11-24	Initiated	Jefferies	Buy
Sep-06-24	Resumed	Robert W. Baird	Outperform
Jul-31-24	Initiated	Truist	Buy
Jun-26-23	Resumed	Oppenheimer	Outperform
Mar-09-23	Initiated	Barclays	Overweight
Feb-28-23	Initiated	Oppenheimer	Outperform
Oct-11-22	Initiated	Morgan Stanley	Equal-Weight
May-31-22	Upgrade	Wells Fargo	Equal Weight → Overweight
Feb-10-22	Initiated	Wells Fargo	Equal Weight
Dec-29-21	Initiated	H.C. Wainwright	Buy
Oct-14-21	Initiated	SVB Leerink	Outperform
Jun-04-21	Resumed	Robert W. Baird	Outperform
Apr-30-21	Resumed	Piper Sandler	Overweight
Apr-30-21	Initiated	RBC Capital Mkts	Outperform
Apr-14-21	Initiated	Berenberg	Buy
Nov-19-20	Initiated	Robert W. Baird	Outperform
Aug-18-20	Initiated	JP Morgan	Overweight
Aug-18-20	Initiated	Needham	Buy
Aug-18-20	Initiated	Piper Sandler	Overweight
Aug-18-20	Initiated	Stifel	Buy

View All

Nurix Therapeutics Inc Stock (NRIX) Latest News

12:22 PM

Can Nurix Therapeutics Inc. recover in the next quarterJuly 2025 Trade Ideas & Long-Term Growth Portfolio Plans - newser.com

12:22 PM

Nov 02, 2025

Full technical analysis of Nurix Therapeutics Inc. stock2025 Growth vs Value & Fast Exit and Entry Strategy Plans - newser.com

Nov 02, 2025

Visual trend scoring systems applied to Nurix Therapeutics Inc.Weekly Risk Report & AI Forecast for Swing Trade Picks - newser.com

Nov 02, 2025

How institutional ownership impacts Nurix Therapeutics Inc. stock2025 Market WrapUp & Safe Entry Zone Tips - newser.com

Nov 02, 2025

How moving averages guide Nurix Therapeutics Inc. tradingDollar Strength & AI Enhanced Execution Alerts - newser.com

Nov 02, 2025

Is Nurix Therapeutics Inc. building a consolidation base2025 Top Decliners & Free Verified High Yield Trade Plans - newser.com

Nov 02, 2025

Will Nurix Therapeutics Inc. stock deliver consistent dividendsJuly 2025 Short Interest & Weekly High Conviction Trade Ideas - newser.com

Nov 02, 2025

Can Nurix Therapeutics Inc. stock hit record highs againTrade Signal Summary & Fast Exit and Entry Trade Guides - newser.com

Nov 02, 2025

Nov 01, 2025

Nurix Therapeutics Inc. stock daily chart insights2025 Volatility Report & Daily Growth Stock Investment Tips - newser.com

Nov 01, 2025

Will Nurix Therapeutics Inc. stock go up soonJuly 2025 Market Mood & AI Based Buy/Sell Signal Reports - newser.com

Nov 01, 2025

Oct 31, 2025

Nurix Therapeutics (NASDAQ:NRIX) CFO Houte Hans Van Sells 3,130 Shares - MarketBeat

Oct 31, 2025

Nurix Therapeutics (NASDAQ:NRIX) Insider Sells $52,313.60 in Stock - MarketBeat

Oct 31, 2025

Nurix Therapeutics Advances NX-5948 Study in B-cell Malignancies - MSN

Oct 31, 2025

Will Nurix Therapeutics Inc. bounce back from current supportPortfolio Performance Report & High Accuracy Buy Signal Tips - newser.com

Oct 31, 2025

Nurix Therapeutics Announces Closing of $250.0 Million Registered Offering of Common Stock - Black Hills Pioneer

Oct 31, 2025

Applying chart zones and confluence areas to Nurix Therapeutics Inc.July 2025 Update & Short-Term Trading Opportunity Alerts - newser.com

Oct 31, 2025

Nurix Therapeutics CFO van Houte sells $40k in shares By Investing.com - Investing.com UK

Oct 31, 2025

Nurix therapeutics CSO Hansen sells $52k in shares By Investing.com - Investing.com UK

Oct 31, 2025

Oct 30, 2025